Ok... I am confident Matt is doing everything possible for the company and its shareholders. I look forward to seeing our revenue numbers. I remain confident the picture going forward looks bright.
The unknowns could be very big. Medical insurance policies, for the first time in history, have been modified to screen for genetic disorders and pay to store for a medical necessity all UCBs of patients who have a medical issue. I believe our pricing makes us a strong storage contract contender from these groups.
I also like the KU study. It illustrates Afford-A-Cord is priced accordingly in the Asian market. Maybe the intent is to make that pricing scheme global and build huge revenues from the annuity for the bio insurance policy.
Then we have research grants and other gov't contracts that we may have or are attempting to get that will improve financials too.
It all starts with the Q to see what direction we're traveling in... I agree revenues should be better.
News 
Market Data 
Discover 
AI
